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How mechanical signals are transmitted in the car-
diac myocyte is poorly understood. In this study, we
produced a tamoxifen-inducible mouse model in
which 1 integrin could be reduced specifically in the
adult cardiomyocyte, so that the function of this in-
tegrin could be assessed in the postnatal and mechan-
ically stressed heart. The expression of 1 integrin
was reduced to 35% of control levels, but function
remained normal at baseline. With aortic constric-
tion, the knockout mice survived but had a blunted
hypertrophic response. Integrin knockout myocytes,
in contrast to controls, showed reduced integrin-
linked kinase expression both at baseline and after
hemodynamic stress; focal adhesion kinase expres-
sion was reduced after stress. Alterations in multiple
signaling pathways were detected in the integrin
knockout group after acute and chronic hemody-
namic stress. Most remarkably, when we challenged
the knockout mice with short-term loading, the ro-
bust responses of several kinases (extracellular sig-
nal–regulated kinase 1/2, p38, and Akt) evident in
control mice were essentially abolished in the knock-
out mice. We also found that reduction of myocyte 1
integrin expression modified adrenergic-mediated
signaling through extracellular signal–regulated ki-
nase, p38, and Akt. Reduction of 1 integrin expres-
sion in the mature cardiac myocyte leads to a varied
response compared with when this protein is reduced
during either the embryonic or perinatal period.
These results show that 1 integrin expression is re-
quired for proper mechanotransductive and adrener-
952gic responses of the adult heart. (Am J Pathol 2012, 180:
952–962; DOI: 10.1016/j.ajpath.2011.12.007)
Hypertrophic growth of the adult heart is caused by
signals beginning at the cell surface through receptors
or channels that, in turn, activate intracellular signaling
cascades and effect nuclear cues that alter gene ex-
pression.1,2 The molecular machinery that directs me-
chanical sensing in the cardiac myocyte is incom-
pletely understood. Important detectors of mechanical
load are the cell surface adhesion receptors, termed
integrins. These receptors transmit information through
a complex of proteins at the Z–disk, where the cyto-
skeleton, sarcomere, sarcoplasmic reticulum, and sar-
colemma are interfaced.3–7
Mammals express more than 18  and 8  integrin
subunits, which heterodimerize to produce more than 24
different receptors. A dominant  integrin subunit in the
cardiac myocyte is 1 integrin. 1D is a 1 splice variant
isoform that associates with  subunits expressed in
myocytes and is the primary 1 integrin isoform ex-
pressed in the postnatal heart.5 The cytoplasmic tail of 1
integrins connects to actin filaments via bridging pro-
teins, such as -actinin, talin, paxillin, and vinculin-
metavinculin.8 Thus, integrins connect the extracellular
matrix to the cytoskeleton and to cytoplasmic proteins. In
addition to their structural and mechanical role, integrins
also transduce signals.9 Because integrins do not pos-
sess enzymatic activity, they signal by triggering down-
stream molecules. Examples include activation of ty-
rosine kinases, such as focal adhesion kinase (FAK),
proline-rich tyrosine kinase 2, or small GTPases, such as
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etal adapter molecules that also propagate intracellular
signals, such as paxillin, integrin-linked kinase (ILK), Src,
Grb2, and Sos. In addition to FAK, integrin cytoplasmic
domains bind numerous other molecules, including me-
lusin and muscle integrin binding protein, both of which
are preferentially expressed in muscle.5 Integrins may
synergize with other types of receptors to cooperatively
signal, as exemplified by the collaborative interactions
between integrins and growth factors.7,11
Global knockout of the murine 1 integrin gene caused
early embryonic lethality.12,13 When 1 integrin expres-
sion was specifically reduced in cardiac myocytes early
in cardiogenesis with Nkx2.5-Cre, ventricular compaction
was perturbed and myocardial proliferation was re-
duced.14 In addition, when the 1 integrin gene was
excised only in ventricular myocytes using a constitu-
tively active Cre-recombinase driven by the endogenous
myosin light chain-2 ventricular promoter, we found the
mice developed myocyte reduction of 1 integrin protein
soon after birth, showed significant and progressive myo-
cardial fibrosis, developed dilated cardiomyopathy by
the age of 6 months, and were intolerant of hemodynamic
loading.15
In the current study, we hypothesized that reduced
expression of 1 integrin in the mature myocyte would
cause defective mechanical signaling but would have
unique effects compared with our prior work when this
Figure 1. Generation and basal analysis of the cardiac myocyte–specific 1
alleles. Primers used for identification of the unexcised and excised alle
cardiac-myocyte specific knockout (cKO) mice were identified by PCR from
3460 and 329 bp in control (Con) mice. These were identified with PCR prim
PCR of the 1 integrin KO mouse DNA, generated after tamoxifen injectio
expression was analyzed by using Western blot analysis (C) and then quant
8 weeks after tamoxifen injection (n  6 in each group). *P  0.0001 versus
analysis of myocardial tissue after reduction of myocyte 1D integrin. No sig
Representative LV apical samples from the various mice are shown. Tri, Maintegrin gene was deleted from cardiomyocytes earlyin cardiogenesis or perinatally. We found that induced
cardiac myocyte–specific excision of the 1 integrin
gene in the adult heart reduced integrin protein ex-
pression effectively and lead to a blunted hypertrophic
response and defective hypertrophic-stress signaling
in the intact heart, most dramatically with short-term
mechanical loading. In addition, we found that adren-
ergic-mediated signaling was abnormal in the isolated
1 integrin–deficient myocyte. These results indicate
the importance of 1 integrin as a cardiomyocyte
mechanotransducer and signaling protein in the ma-
ture cardiac myocyte.
Materials and Methods
Generation of Mice with Inducible Cardiac
Myocyte–Specific Excision of the 1
Integrin Gene
Floxed 1 integrin mice were constructed as previously
reported15 and diagrammed in Figure 1A. 1 Integrin
floxed mice were bred to the transgenic strain, -myosin
heavy chain (MHC) Mer-Cre-Mer,16 which contains a ta-
moxifen-inducible, cardiac myocyte–specific Cre-recom-
binase driven by the -MHC promoter. The background
knockout mice. A: Diagrams of 1 integrin wild-type, floxed, and excised
esignated as Pr1, Pr2, and Pr3. WT, wild type. B: Genotypes of the 1
enomic DNA. PCR fragments from floxed bands that were not excised were
s Pr1-Pr3 and Pr2-Pr3, respectively. A 469-bp excised band was detected by
primers Pr1-Pr3 were used for this reaction. C and D: 1 Integrin protein
densitometry (D) to show cKO mice with 35%  5% of control values 4 to
ction. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. E: Histological
differences were detected on histological analysis of the myocardial tissue.
ichrome stain.integrin
le are d
heart g
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oil injestrain was mixed C57 Bl6/Swiss-black.
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Floxed Integrin Allele via PCR
PCR was used to determine that Cre-mediated excision
of the 1 integrin floxed gene had occurred. For this, we
used primers as shown in Figure 1A: primer (Pr) 1, 5=-
AGGAGACTGTGTAGATGGACATT-3=; Pr2, 5=-TATGAG-
GCTCCTTGATTGGTCA-3=; and Pr3, 5=-GACCAGGAT-
GAAAGGTCAAA-3=. The PCR conditions were as follows:
2 minutes at 94°C; 12 cycles of 10 seconds at 94°C, 30
seconds at 57°C, and 3 minutes at 68°C; 18 cycles of 15
seconds at 94°C, 30 seconds at 57°C, and 3 minutes
30 seconds at 68°C; and 7 minutes at 68°C. PCR was
performed with the Expand long Template PCR System
(Roche Diagnostics, Indianapolis, IN) containing 1.75
mmol/L MgCl2, 3.75 U Expand long Template enzyme,
0.35 mmol/L deoxy-NTPs, 0.3 mol/L of each primer, and
1 g of genomic DNA from the heart. Resultant bands
were 3460 and 329 bp in control mice and a 469-bp
excised band in the 1 integrin cardiac-myocyte specific
knockout (cKO) mice.
Tamoxifen Induction
Age-matched, 2- to 3-month-old 1 flox/flox/-MHC Cre
mice were injected i.p. with either 4-OH tamoxifen (0.5 mg/
100 L) in peanut oil once daily for 10 days or tamoxifen
base (40 g/g body weight) in corn oil for 10 days, followed
by an additional 5 days of injections at 30 days after com-
pletion of the first injection sequence. The identical injection
of oil alone was used to generate control mice in littermates.
For all studies, except as noted, mice were analyzed at 60
days after the conclusion of the injection period or were
subjected to surgical procedures as described.
Protein Preparation, Western Blot Analysis, and
Immunomicroscopy
Whole hearts were excised from mice, and tissue sec-
tions were frozen in liquid nitrogen. Protein preparation
and Western blot analysis procedures were performed as
previously described.17 Immunostaining was performed
by standard methods.15 Deconvolution microscopy was
performed using Deltavision software (Applied Precision,
Inc., Seattle, WA) or a Zeiss AxioObserver (Carl Zeisss
MicroImaging GmbH, Göttingen, Germany) microscope
and analyzed with Axiovision software. Cross-sectional
measurements were performed, and calculations were
made using ImageJ software (NIH, Bethesa, MD).
Cardiac Myocyte Isolation, Culture, Stimulation,
Kinase, and TUNEL Assays
Single cardiac myocytes were isolated from adult mice
via enzymatic digestion of Langendorff perfusedhearts.18 For
analysis of protein expression after surgery, cells were
prepared for analysis without culturing. For isoproterenol
stimulation studies, cells were studied at 30 days after the
conclusion of tamoxifen injection, cultured overnight on
laminin-coated plates, and then, as indicated, stimulationwas performed with isoproterenol at 1 mol/L for 30 min-
utes. After isoproterenol stimulation, Western blot analy-
sis was performed (as previously described) or in vitro
kinase activities for p38, p42/44 mitogen-activated pro-
tein kinase (MAPK), and Akt–protein kinase B were de-
tected with nonradioactive assay kits using appropriate
substrates for the immunoprecipitated proteins (Cell Sig-
naling Technology, Beverly, MA). For TUNEL assays,
cryotome sections of heart samples were obtained
from the control and cKO mice subjected to sham or
transverse aortic constriction (TAC) surgical proce-
dures. Sections were processed per manufacturer’s
instructions (ApopTaq Red In Situ Apoptosis Detection
Kit, catalogue number S7165; Millipore Inc., Hayward,
CA). Monoclonal anti--sarcomeric actinin (number
A7811; Sigma, St Louis, MO) was used to counterstain
cardiomyocytes. Greater than 1000 myocytes for at
least three different mice in each of the four groups
were evaluated for the presence of signal, and results
were expressed as percentage myocytes detected as
TUNEL positive.
Echocardiography, Hemodynamic Analysis,
and TAC
Methods for these procedures were previously detailed.15
TAC was performed using anesthesia with ketamine (100
mg/kg) and xylazine (2.5 mg/kg) injected i.p. Transthoracic
echocardiography was performed using a Vevo 770 (Visu-
alsonics, Toronto, ON, Canada) machine, with mice anes-
thetized with isoflurane anesthesia by use of a vaporizer
(model 100-F; Ohio Medical Instruments, Cincinnati, OH).
Isoflurane was maintained during spontaneous breathing of
1.25% isoflurane in 100% O2 at a flow rate of 1 L per minute
via a small nose cone.
Antibodies
The primary antibodies used in these experiments were
to detect the following: 1D-integrin, produced in our own
laboratory19; glyceraldehyde-3-phosphate dehydroge-
nase [RDI-TRK5G4-6C5 (Research Diagnostics, Flan-
ders, NJ) or SC32233 (Santa Cruz Biotechnology, Santa
Cruz, CA)]; phosphorylated FAK(PY397) (number
44624G; Invitrogen, Carlsbad, CA); total FAK (number
06-543) and 3 integrin (number 04-1060; Millipore, Bil-
lerica, MA); vinculin (number V9131; Sigma); paxillin
(number 2541; BD Transduction Labs, San Jose, CA);
and ILK (number 3862), phosphorylated paxillin (number
2541), phosphorylated p44/42 MAPK (number 9101), to-
tal p44/42 MAPK (number 9102), phosphorylated Elk-1
(number 9181), Elk-1 (number 9182), phosphorylated
p38 MAPK (numbers 9211 and 9216), total p38 (number
9212), phosphorylated Akt (number 9271), total Akt
(numbers 9272 and 4691), phosphorylated glycogen
synthetase kinase (GSK) 3/ (number 9331), total
GSK3 (number 9315), phosphorylated activating tran-
scription factor 2 (ATF-2) (number 9221), ATF-2 (number
9226), cleaved caspase 3 (number 9664), and 5 integ-
rin (number 4708) (all from Cell Signaling Technology).
-3=
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Analysis
Total RNA was isolated from adult mouse ventricular
myocytes from control and 1 cKO mice by using
RNeasy (Qiagen, Valencia, CA), according to the manu-
facturer’s instructions. cDNA was synthesized from 1 g
of RNA in 20 L with Superscript III, containing reverse
transcriptase with random hexamer primers (Invitrogen) by
incubation for 1 hour at 50°C. RT-qPCR analysis was per-
formed (7300 Real-Time PCR System; Applied Biosystems,
Carlsbad, CA) by using sets of primer pairs, as listed in
Table 1. Data were analyzed with 7300 software version
1.3.1 (Applied Biosystems). mRNA levels were measured in
three replicates. Fold changes in integrin subunit mRNA
were normalized to ribosomal protein large P0 levels.
Statistical Analyses
All results were expressed as the mean SEM. Statistical
analysis was performed using the two-tailed Student’s
t-test or an analysis of variance, with P 0.05 considered
statistically significant.
Results
Generation of Inducible, Cardiac
Myocyte–Specific 1 Integrin Knockout Mice
Floxed 1 integrin mice were constructed such that the
exon 2 (containing the translational start site) and exon 3,
of the 1 integrin gene, were flanked by loxP recognition
sites15 (Figure 1A). Homozygous 1 integrin flox/flox
mice were bred to -MHC Mer-Cre-Mer transgenic mice,
which contain a tamoxifen-inducible Cre-recombinase
driven by the cardiac myocyte–specific -MHC pro-
moter.16 The interbred mice (1 integrin Lox/Lox  Mer-
Cre-Mer, termed cKO) were injected with tamoxifen. 1
Integrin Lox/Lox  Mer-Cre-Mer mice injected with oil
(diluent) were used as controls for the study. No effect of
tamoxifen injection into the -MHC Mer-Cre-Mer was
seen on either expression of 1 integrin or physiological
function (as assessed by echocardiography) when eval-
uated at up to 12 weeks after injection (data not shown).
Therefore, diluent-injected mice were used as controls.
At 60 days after completion of the injections, we as-
sessed total heart DNA for gene excision and protein for
expression of the muscle-specific isoform 1D integrin
(Figure 1, B–D). Gene excision occurred, and a reduction
Table 1. Primer Sets Used for Analysis of Integrin Transcript Exp
Integrin Forward primer
1D 5=-CAAGTGGGACACGCAAGAAA
3 5=-TATGTGGTGGAAGAGCCTGA
5 5=-TGGGTAGACACCATCGTCAA
6 5=-CAGGCTGCTGTGTGTAAGGA
7 5=-GAGTCAACCAGACGGTGGAT
8 5=-GGAGTGTGAAGGTGGCAGATin 1D integrin protein to 35% 5% of control values wasdetected by using Western blot analysis in the tamoxifen-
injected versus control mice. To assess if the expression
of other  integrin subunits might be increased to com-
pensate for loss of 1 from the myocyte, we performed
quantitative RT-PCR (RT-qPCR) on RNA from control and
cKO myocyte samples (see Supplemental Figure S1A at
http://ajp.amjpathol.org). In agreement with the Western
blot analysis data, 1D integrin transcript levels (the
dominant 1 integrin in myocytes) was reduced. Of the
other  subunits tested, only 7 integrin was statistically
increased. Therefore, we performed Western blot analy-
sis for this subunit on myocyte protein samples. Also,
because the 3 subunit has received attention as being
important for cardiac myocyte hypertrophy,20 we evalu-
ated if protein expression of this integrin in the cKO group
was increased compared with control cardiac myocytes.
No differences were detected between control and cKO
protein lysates for either subunit (see Supplemental Fig-
ure S1, B and C, at http://ajp.amjpathol.org).
Cardiac Form and Function in Basal and
Hemodynamically Loaded Hearts after Adult 1
Integrin Gene Excision
Next, we characterized mice in the basal state. Histologi-
cally, there were no abnormalities and, in particular, no
significant fibrosis noted in the gene-excised mice (Figure
1E). The functional importance of 1 integrin in the mature,
fully developed heart was evaluated. Baseline echocardio-
graphic data, analyzed up to 8 weeks after gene excision,
showed that hearts of the integrin cKO mice had no signif-
icant differences from control-injected littermates (Table 2).
Reverse primer
5=-CGTCCATAGTTTGGATTCTTGAAAT-3=
5=-CAGAGTAGCAAGGCCAATGA-3=
5=-TGGGACGTTCTGTGTAGCTG-3=
5=-TGCTGTCCATTCCAAAATGA-3=
5=-TCCTCTGAGAAGCCAAGAGC-3=
5=-GGCCTTGGAGTTGACACAGT-3=
Table 2. Baseline Echocardiographic Data Show No
Statistically Significant Differences between Control
and 1 cKO Mice
Variable
Control group
(n  10)
1 cKO group
(n  10)
BW (g) 23.5  0.91 24.9  0.6
HR (bpm) 545  6 525  14
LV EDD (mm) 3.67  0.04 3.66  0.9
LV ESD (mm) 2.15  0.09 2.26  0.04
LV SDd (mm) 0.54  0.01 0.55  0.01
LV PWd (mm) 0.65  0.02 0.66  0.02
%FS 41  2 39.6  1.1
LV mass (mg) 69.2  3 69.9  2
Mean Vcf (cir/second) 8.3  0.3 7.7  0.4
BW, body weight; cir, circumferences; EDD, end-diastolic diameter;
ESD, end-systolic diameter; %FS, percentage fractional shortening; HR,ression
-3=
-3=
-3=
-3=
-3=heart rate; PWd, posterior wall thickness in diastole; SDd, septal thickness
in diastole; Vcf, velocity of circumferential fiber shortening.
stole (ID
groups
956 Li et al
AJP March 2012, Vol. 180, No. 3Previously, when we had produced mice with 1
integrin reduction in cardiac myocytes beginning soon
after birth, we found that the mice spontaneously
developed cardiomyopathy and were intolerant of he-
modynamic loading for even a short period.15 We hy-
pothesized that reduced expression of this mechano-
transduction protein in the adult might have a varied
effect given that protein reduction would occur after
the myocyte had fully matured, with normal amounts of
this  integrin subunit. Tamoxifen-injected and control
mice were subjected to TAC beginning 60 days after
gene excision. Transaortic pressure gradients, deter-
mined via catheterization of left and right carotid arter-
ies, were comparable between the cKO and control
mice (110  55 versus 144  21 mmHg). Serial echo-
Figure 2. Decreased expression of cardiac myocyte 1 integrin in the c
hypertrophic response of the cKO mice was altered. Serial echocardiograp
Serial echocardiographic analyses demonstrated that LV intraventricular s
and LV mass had varied responses in the cKO versus control mice. *P 
weight/tibia length (HW/TL) was reduced in cKO versus control, comme
0.05 versus control TAC (n  6 each). E: Myocyte cross-sectional area (CSA
data. *P  0.05 versus sham of each group, †P  0.05 versus control TAC
various groups illustrating cell sizes when staining tissue with wheat germ
internal dimension in diastole (IDd); and H, LV internal dimension in sy
at 2 weeks after TAC in the cKO group but is otherwise similar betweencardiographic analyses of these mice showed that theyhad a blunted hypertrophic response after hemody-
namic loading [reduced increases in wall thicknesses
and left ventricular (LV) mass] compared with controls
(Figure 2). The echocardiographic parameters were in
agreement with morphometric and myocyte cross-sec-
tional area measurements that also were reduced in
the cKO mice versus controls. Despite this response,
with long-term hemodynamic loading, both groups of
mice developed ventricular dilation and decreased
cardiac function. No histological differences were noted in
heart specimens obtained from the various groups after
TAC, with only mild fibrosis noted in both (see Supplemental
Figure S2 at http://ajp.amjpathol.org). These results indi-
cated that if 1 integrin expression is reduced after the
cardiac myocyte is fully mature, normal mechanical re-
e alters response of the adult heart to hemodynamic loading. A–C: The
aled a blunted hypertrophic response in the integrin-deficient cKO mice.
ickness in diastole (IVSd), LV posterior wall thickness in diastole (PWd),
P  0.001 versus control at the same time point (n  6 each). D: Heart
with echocardiographic data. *P  0.05 versus sham of each group, †P 
educed in cKO versus control mice, in agreement with echocardiographic
for each group). F: Representative microscopy of myocardial tissue from
inin. G and H: Chamber dimensions were similar between groups [G, LV
s)] (n  6). I: The percentage fractional shortening (%FS) was reduced
. *P  0.05 versus control at the same time point (n  6).KO mic
hy reve
eptal th
0.01, **
nsurate
) was r
(n  60
agglutsponses to hemodynamic load are altered.
expression of phosphorylated (P) protein was normalized to total (T)
protein in all cases (n  5 to 7).
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Following Long-Term Hemodynamic Loading
Are Altered by 1 Integrin Deficiency
After surgical manipulations, we first assessed the ex-
pression of 1 integrin in control and cKO samples (Fig-
ure 3A). This was important because the tamoxifen-in-
duced 1 integrin gene excision allowed for residual
expression of the protein. We found that, with TAC, the
control mice increased integrin expression significantly to
122%  7% versus sham control, whereas the cKO ex-
pression levels remained lower than that noted in sham
cKO (28%  4% of control sham). Therefore, with TAC,
1 integrin expression in cKO hearts was 23% of control
values. Given the blunted hypertrophic response of these
mice, we next assessed the expression and activity levels
of proteins that are membrane proximal to integrins. We
first examined expression of activated FAK (p-Y397) or
paxillin proteins in whole heart tissue at 4 weeks after
sham or TAC surgery (Figure 3, B and C). FAK or paxillin
activity was not increased by TAC in either the control or
the cKO group, nor was there any difference noted be-
tween the control and integrin-deficient mice in either the
sham or TAC state.
Next, we examined expression of various integrin-
linked adapter proteins specifically in myocytes isolated
4 weeks after the sham or TAC surgery (Figure 4). Unlike
the whole heart, we found that, with TAC, myocytes from
control mice had an approximate 2.5-fold increase in total
FAK protein, whereas the cKO myocytes did not have an
Figure 4. The expression of proteins that are membrane proximal to integ-
rins was altered in the cKO myocytes. Myocytes were isolated from sham and
TAC hearts 4 weeks after surgery. A: Total FAK (T-FAK) was similar in control
and cKO basal myocytes but increased in the control, although not cKO,
myocytes after TAC. *P  0.05 versus sham control, †P  0.02 versus control
TAC (n  3 each). B: Total paxillin (T-Pax) expression was similar in control
and cKO myocyte samples (n  6 each). C: ILK expression was reduced in
the basal (sham) and hemodynamically loaded cKO myocytes versus control.
*P  0.05 versus control of each respective group, sham and TAC (n  6
each). D: Vinculin levels were similar in control and cKO sham and TAC
myocytes (n  6). The expression of noted proteins was normalized toFigure 3. Expression of 1 integrin and activity of proximal integrin
effectors in sham and TAC heart samples after 4 weeks of aortic constric-
tion. A: 1 Integrin expression was increased by TAC in control mice,
whereas it remains significantly reduced in cKO mice. *P  0.05 versus
control sham, †P  0.05 versus control sham or TAC. GAPDH, glyceral-
dehyde-3-phosphate dehydrogenase. Data for FAK (B) and paxillin (C)
are shown. No differences in activated FAK or paxillin were noted in
either group after TAC, nor were there differences between groups. Theglyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression in all
cases.
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hemodynamic loading nor produced a difference be-
tween control or cKO expression between sham or TAC
groups. ILK, a critical adapter that has been linked to
myocardial growth,21,22 showed reduced expression in
both the sham and TAC cKOmice, relative to controls. No
difference was detected in vinculin expression between
groups.
We then examined the effects of the long-term loading
(4 weeks after TAC) on kinases modulated by integrins
and important for the hypertrophic response (Figure 5).
Although no significant changes were noted in extracel-
lular signal–regulated kinase (ERK) 1 or 2, p38 activity
was significantly increased in the control samples but
had a blunted response in the cKO samples. Sham-
treated cKO mice also showed increased Akt activity
versus control. After TAC, the cKO mice showed reduced
Akt activity compared with sham cKO mice, whereas
control mice showed no significant change. GSK3
showed a robust response with loading of control mouse
hearts, but this response was reduced after TAC in cKO
versus both sham cKO and control TAC. Finally, we eval-
uated for differences in programmed cell death between
Figure 5. Long-term mechanotransductive signals were altered in the cKO
mice; 4 weeks of TAC produced robust activation of several kinases in the
myocardium of control mice, with altered responses in the cKO group. A:
Representative Western blot analyses of respective proteins. B: Graphical
analysis of normalized activities of noted proteins. No significant change in
ERK1 or ERK2 activation was noted in either the control or cKO group; no
differences between these groups were found. p38 activity was increased by
TAC in the control, but not in the cKO, group. Akt activity was increased in
sham cKO relative to control but reduced in cKO with TAC in contrast to no
significant change in control. GSK3 was increased by TAC in control, but
reduced in cKO, relative to both sham cKO and TAC control groups. In all
cases, activity was determined by normalizing phosphorylated kinase to total
kinase protein expression. *P  0.002, **P  0.05 versus control sham; †P 
0.02, ††P  0.005 versus control TAC; and ‡P  0.05 versus cKO sham (n 
5 to 7 for all).the control and cKOmice in both the sham state and afterTAC. Although the number of TUNEL-positive cells in-
creased in TAC compared with sham, no differences
were seen between the control and cKO groups (see
Supplemental Figure S3 at http://ajp.amjpathol.org). In
addition, no difference in caspase-3 cleavage was de-
tected between groups (data not shown).
Short-Term Mechanotransductive Signaling Is
Significantly Blunted When Cardiac Myocyte 1
Integrin Is Reduced
Mechanotransductive reactions of the myocardium have
an initial response on short-term stimulation; thus, we
next examined if a range of kinases might be activated in
the heart with acute hemodynamic stress. Thus, sham or
TAC surgical procedures were performed in the control
and cKO mice, with analyses performed on tissues har-
vested after only 10 minutes of stress (Figure 6). This time
period was based on preliminary studies in control mice,
which showed maximal short-term activation of this group
of proteins at this time point (data not shown). With this
short-term event, no differences in the amount of FAK
activation were noted in either sham group, nor was there
any significant change with TAC. Next, we evaluated the
activities of ERK1, ERK2, Gsk3, and p38. With sham
Figure 6. Short-term mechanotransductive signals were blunted in the cKO
mice; 10 minutes of TAC produces robust activation of numerous kinases in
the myocardium of control mice and blunted responses in cKO. A: Repre-
sentative Western blot analyses of respective proteins. B: Graphical analysis
of normalized activities of noted proteins. No significant changes in FAK
activation were noted, but in contrast, activation of ERK1, ERK2, Gsk3, and
p38 was robust in control mice, but significantly blunted in cKO animals. In
addition, ERK1 and Akt activity was increased in sham cKO versus sham
control, although the activation of Akt after TAC was also blunted. In all
cases, activity was determined by normalizing phosphorylated kinase to total
kinase protein expression. *P  0.05, **P  0.005 versus control sham; †P 
†† ¶0.05, P  0.01 versus control TAC; and P  0.05 versus cKO sham (n  6
for all).
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cKO group samples. TAC produced robust responses in
the control mice, ranging from a greater than threefold
activity increase (over sham) in GSK3 to a greater than
eightfold increase in ERK2. In contrast, the response of
all of these kinases was essentially abolished in the cKO
group. Furthermore, in the sham state, the cKO group
had an approximate threefold up-regulation of Akt activity
relative to control, although the response to TAC was also
blunted, like the other kinases.
Signaling Events Are Altered in the 1 Integrin
KO Adult Cardiomyocyte Stimulated with
Isoproterenol
Because, in addition to mechanotransduction, integrin
and G-protein–coupled signaling events have been
linked in various cell types, we next assessed isolated
adult cardiac myocytes from the cKO and control ani-
mals. We evaluated cells in the basal state and investi-
gated if the cardiac myocytes deficient in 1 integrin
would have altered adrenergically mediated signaling
properties. Cells were isolated from the mice, cultured
overnight, and then stimulated with the -adrenergic re-
ceptor agonist isoproterenol for 30 minutes. For in-
creased sensitivity, we studied the activity of p38 MAPK,
ERK1/2, and Akt using substrate activity assays as op-
posed to using Western blot analysis techniques with
phosphorylated specific antibodies (Figure 7). In all
cases, basal activities of the kinases in cKO myocytes
were comparable to those in control cells. However, with
isoproterenol stimulation, the control cells displayed a
robust activation of all three enzymatic activities, whereas
the cKO cells showed no significant change from the
baseline value.
Discussion
There are numerous diseases that result in hypertrophy of
the myocardium, many of which may progress to heart
failure. Given this, there has been much interest in un-
derstanding how mechanical and humoral responses are
transmitted to growth responses in the heart. Indeed,
mechanical stresses may activate adrenergic signals.
Because integrins are important mechanotransducers,
we hypothesized that reduced expression of 1 integrin
in the mature myocyte would lead to altered responses of
the heart and myocyte to stress, and that this response
would be varied in the mature heart as opposed to when
the cardiomyocyte was made deficient in this integrin
from early in development. Adult mice were made defi-
cient in 1 integrin to levels approximately 35% of control
values. Basally, the integrin-deficient adult heart showed
no alterations in cardiac structure or function. When sub-
jected to hemodynamic loading of the LV by TAC, the
development of hypertrophy was blunted, yet with con-
tinued loading, ventricular function declined in cKO, as in
controls. More important, TAC significantly increased
1D integrin expression in the control mouse heart, a
response that was not mounted in the cKO group despitemaintenance of some residual 1D protein. Isolated myo-
cytes showed reduced ILK expression in both the basal
and hemodynamically stressed cKO mice versus con-
trols, with reduced FAK expression after TAC. Paxillin and
vinculin expression levels were unchanged in the cKO
Figure 7. Adrenergically stimulated signaling events were altered in the
isolated cKO adult cardiomyocytes. Short-term isoproterenol (ISO or Iso)
stimulation caused increased activity levels of p38 (A), ERK (B), and Akt (C)
in control (Cont) adult myocytes but not in myocytes from 1 integrin
knockout mice. *P  0.05 for basal versus Iso-stimulated control cells, †P 
0.05 versus Iso-stimulated KO cells. Representative Western blot analyses are
shown. Cells were studied at 30 days after conclusion of tamoxifen injection
(n  3 in each group).group. In addition, alterations in the response of p38, Akt,
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Most remarkably, when we challenged the mice with
short-term hemodynamic loading, the control mice had
robust increases in activation of ERK1/2, GSK3, p38,
and Akt, whereas the cKO group did not. In addition, the
activity of ERK1 and Akt was significantly increased in the
cKO sham group versus controls. At this point, FAK was
not activated by TAC. In addition to alterations in mecha-
notransduction, reduction of myocyte 1 integrin also
modified adrenergic-mediated signaling through p38,
ERK, and Akt.
These data indicate that if the heart has fully matured
before myocyte 1 integrin expression is significantly
reduced, basal function can be maintained, but when
challenged with increased mechanical loading, the hy-
pertrophic response is blunted. Prior work14,15 showed
that reduction of 1 integrin in the early embryonic myo-
cyte or in the perinatal period produced developmental
abnormalities or rapid alterations in the formed myocar-
dium. In contrast to the mice examined herein, when we
reduced 1 integrin expression in the myocyte near birth,
TAC caused rapid mortality.15 Therefore, we conclude
that reduction of 1 integrin protein expression is better
tolerated by the adult myocyte than when protein is re-
duced during the important period of cardiac maturation.
This is likely related to the varied roles of 1 integrin
protein during cardiogenesis (eg, myocyte proliferation
and ventricular maturation14) versus that necessary after
the myocyte and heart have fully formed.
Integrins do not themselves possess intrinsic kinase
activity. Rather, their signaling functions require assem-
bly of scaffolding proteins and activation of downstream
cytoplasmic kinases, such as ILK and FAK. Our data
showed that, with reduction of 1 integrin, ILK expression
was also reduced both in the basal mice and after TAC.
As a protein that binds to the  integrin cytoplasmic
domain, it is highly likely that with loss of integrin expres-
sion in the myocyte, ILK cannot be positioned appropri-
ately in the costamere and, therefore, may have acceler-
ated degradation. ILK deletion specifically in murine
cardiac myocytes also leads to dilated cardiomyopa-
thy.22 FAK is also an important kinase necessary for
integrin function. We found that, after hemodynamic load-
ing, the cKO did not increase FAK expression in cardiac
myocytes, like controls. Differences in FAK expression
were only detected in isolated myocytes, but not in whole
heart tissue, because the amount of FAK in nonmyocytes
is considerably more than that in myocytes themselves
(A.M.M. and R.S.R., unpublished data). These data re-
garding FAK are interesting in that cardiac myocyte–
specific excision of the FAK gene in mice has resulted in
relevant, but varied, phenotypes.23,24 In one study,23 re-
duction of myocyte FAK had no basal effect on the heart
but had a modest effect on the TAC-induced hypertro-
phic response of the myocyte/heart, predisposed to long-
term TAC-induced cardiac dysfunction, and resulted in a
blunted activation of ERK, at 1 and 4 days after TAC.
Deletion of a variant FAK-floxed allele by another group24
also showed no basal phenotype but resulted in LV dila-
tion, without changes in wall thickness by 10 days after
TAC. Given these results and that our integrin-deficientmice could not increase the expression of ILK or FAK in
response to hemodynamic load, it is likely that these
proteins downstream of 1 integrin played substantial
roles in the abnormal hypertrophic response detected in
our mice.
In addition to evaluation of these proximal integrin link-
ers, we also tested how loss of 1 integrin altered myo-
cyte mechanical and adrenergic-mediated signaling, be-
cause both types of signaling events can stimulate
hypertrophic growth. With acute mechanical stress, the
normal robust activation of ERK1/2, p38, Akt, and GSK3
was all strongly blunted in 1 cKO mice, indicating an
essential role of 1 integrins in the early response to
mechanical stimulation. Similarly, the activities of ERK,
p38, and Akt were also inhibited in adrenergically stimu-
lated, isolated adult myocytes from cKO mice. Therefore,
cardiac myocyte integrins are mediators of both mechan-
ical and humoral events. The roles of the kinase pathways
analyzed have been extensively studied in cardiac hy-
pertrophy, although without a full consensus about the
details of their function.25,26 Studies,27,28 including some
of our own, have shown that ERK1/2 is rapidly activated
after short-term mechanical loading of the heart and that
integrin activation may specifically lead to ERK1/2 acti-
vation. Remarkably, cardiac myocyte– specific Cre-me-
diated ablation of ERK2 in an ERK1-null background al-
lowed for survival of the mice, although with eventual
development of a dilated cardiomyopathic phenotype.29
With TAC, the ERK1//ERK2 cKO group died rapidly,
whereas normal responses were detected to TAC in both
the ERK1/ and the ERK2 cKO group alone. We found
that integrin deficiency caused reduced ERK activity after
short-term hemodynamic and adrenergic stimulation;
however, in the long-term, the activity was normal. Thus,
it is possible that contributions to the blunted hypertro-
phic response we detected in our cKO mice might come
from these short-term perturbations in ERK activity, which
is not dissimilar from the reduction in ERK activity and the
reduced hypertrophic responses, detected in FAK cKO
mice challenged with TAC.23
Our data also showed reduced activation of p38 in
cKO hearts and cells after both short- and long-term
mechanical loading, as well as adrenergic stimulation.
The function of p38 in cardiac growth, stress responses,
and progression to heart failure has also been com-
plex,30–34 with some studies suggesting p38 is prohyper-
trophic and others indicating that p38 was not required
for pressure overload–induced hypertrophy. Similarly, the
Akt–protein kinase B pathway has also been linked to
cardiac growth and its manipulation has provoked a
spectrum of phenotypes, ranging from profound cardiac
failure to sudden death and to supranormal contractil-
ity.35–39 The variance of expression level and the type of
Akt construct used for these studies influenced the phe-
notypic response. Furthermore, GSK3 can be inhibited
(phosphorylated) by hypertrophic stimuli. With cardiac
myocyte–specific transgenic increases in GSK3 activity,
the mouse heart was basally normal but had a reduced
ability to hypertrophy in response to adrenergic stimula-
tion or hemodynamic loading.40 The changes we noted in
our mice speak to the complexities of these response
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cytes had increased Akt activity, relative to control. It is
possible that the basal activation of Akt in the cKO mice
occurred as a protective response of the integrin-defi-
cient cardiac myocytes to cellular stress, despite the
absence of functional abnormalities at this time point.
Still, both acute and chronic TAC lead to a reduced
stimulation of Akt and GSK3 in the cKO mice. Likewise,
adrenergic stimulation of the integrin-deficient cells had a
reduced Akt activation. These blunted responses may
have also contributed to the blunted hypertrophic re-
sponse, and this hypothesis is supported by a prior study
focused on the integrin-binding protein, melusin. Like our
mice, these melusin KO mice also showed a blunted
hypertrophic response after TAC and then were predis-
posed to heart failure.41 In the short-term, these mice also
showed reduced phosphorylation of Akt and GSK3.
These data are directly in line with our findings herein.
A limitation of our study is lack of a full understanding
of why the integrin cKO mice had only a blunted hyper-
trophic response but did not dilate or fail significantly
faster than controls. We hypothesize that this can be
attributed to the residual integrin expression that re-
mained in our Cre-lox–deleted mice and also to the ex-
tremely high degree of aortic constriction (100-mmHg
gradient) that ultimately leads to decreased cardiac func-
tion, even in the control mice that retained normal integrin
expression. Having mice in a mixed genetic background
may have influenced some variability of our data, but
littermate controls mitigated any concern that the mixed
background may have altered our results.
What relevance might these data have for human dis-
ease? To our knowledge, there are no genetic mutations
in 1 integrin that have been detected in humans. Be-
cause 1 integrin is ubiquitously expressed, it is likely
that genetic mutations in this integrin subunit would be
embryonically lethal. Still, 7 integrin, which combines
with 1 as a dominant muscle heterodimer, has identified
mutations in patients with congenital muscular dystro-
phies, although the mutant effects on cardiac function are
unknown.42 Immunolocalization of 71 was also dis-
turbed in patients with muscular dystrophy who had a
merosin deficiency.43 In addition, 71 expression was
increased in patients with Duchenne’s muscular dystro-
phy and may be a potential protective therapy for pa-
tients with this disease.44,45 Also germane is that 1D
integrin protein has been either reduced or cleaved in
patients with ischemic and dilated cardiomyopathy,46,47
and that integrin expression levels return to normal as the
reverse remodeling occurs with mechanical unloading of
the failing heart through use of an LV assist device. Fi-
nally, in addition to integrins themselves, mutations in
integrin-linked protein ILK, which we found decreased in
expression in our cKO mice, have also been identified
in patients with cardiomyopathy,48 and ILK expression
has been detected as being up-regulated10-fold in the
failing human myocardium.49 Given this, we would sug-
gest that mutation of 71 integrins could potentially lead
to cardiac dysfunction, particularly in the face of a sec-
ond hit, such as hypertension or valvular disease, and
that augmented expression of these integrins could like-wise be tested as a therapy for cardiomyopathies of
many types. Further work is necessary to explore this
tenet.
In conclusion, our results clearly show novel informa-
tion that 1 integrins are critically involved in short- and
long-term cardiac myocyte mechanotransduction and in
the response of cardiac myocytes to adrenergic stimula-
tion. Our data speak to the complexities in understanding
how short- and long-term mechanical and adrenergic
events summate in the hypertrophic and potentially fail-
ing myocardial phenotype. How modulation of integrin
expression or function might predispose to cardiac dys-
function, and whether augmented integrin function could
be used therapeutically to prevent myocardial disease,
clearly requires further study.
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